JPRN-UMIN000004197已完成2 期
Phase II Study of FOLFOX + Erbitux as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild type - JACCRO CC-05 study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Synchronous multiple malignancy or metachronous multiple malignancy within 5 years disease free interval 2.Symptomatic brain metastases 3.Severe infectious disease 4.Interstitial lung disease or pulmonary fibrosis 5.Comorbidity or history of heart failure 6.Sensory alteration or paresthesia interfering with function 7.Large quantity of pleural, abdominal or cardiac effusion 8.Severe comorbidity (renal failure, liver failure, hypertension, etc) 9.Prior radiotherapy for primary and metastases tumors 10.Men/women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. Women with a positive pregnancy test 11.History of severe allergy 12.History of allergy for L-OHP and other platinating agent 13.Prior treatment of cetuximab or L-OHP 14.Any other cases who are regarded as inadequate for study enrollment by investigators
研究者
相似试验
进行中（未招募）
不适用
FLOX + Erbitux. 1. line treatment to patients with metastatic colorectal cancer and wild type K-RAS tumor. A phase II study. - Nordic 7.5EUCTR2007-007834-21-DKOdense University Hospital86
已完成
2 期
FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal CancerEsophageal Cancer Stage IIINCT00578201Assistance Publique - Hôpitaux de Paris80
已完成
2 期
Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric CardiaUnresectable Adenocarcinoma of the EsophagusMetastatic Adenocarcinoma of the EsophagusUnresectable Adenocarcinoma of Gastric CardiaMetastatic Adenocarcinoma of Gastric CardiaNCT00591123Translational Oncology Research International38
已完成
1 期
Phase I study of FOLFOXIRI+Bev for unresectabl colorecatal cancernresectable colorectal cancerJPRN-UMIN000010442Aichi Cancer Center Hospital20
已完成
4 期
Pilot study of FOLFOX or XELOX Therapy Versus FOLFOX or XELOX + PSK Therapy as Postoperative Adjuvant Therapy for Histological Stage IIIa and IIIb Colon CancerColon cancerJPRN-UMIN000006134Tokai University School of Medicine20